van Herwerden LA - Search Results

1

In Situ Tissue Engineering of Functional Small-Diameter Blood Vessels by Host Circulating Cells Only.

Talacua H, Smits AI, Muylaert DE, van Rijswijk JW, Vink A, Verhaar MC, Driessen-Mol A, van Herwerden LA, Bouten CV, Kluin J, Baaijens FP. Talacua H, et al. Among authors: van rijswijk jw, van herwerden la. Tissue Eng Part A. 2015 Oct;21(19-20):2583-94. doi: 10.1089/ten.TEA.2015.0066. Epub 2015 Aug 25. Tissue Eng Part A. 2015. PMID: 26200255

2

Imaging the In Vivo Degradation of Tissue Engineering Implants by Use of Supramolecular Radiopaque Biomaterials.

Talacua H, Söntjens SHM, Thakkar SH, Brizard AMA, van Herwerden LA, Vink A, van Almen GC, Dankers PYW, Bouten CVC, Budde RPJ, Janssen HM, Kluin J. Talacua H, et al. Among authors: van herwerden la. Macromol Biosci. 2020 Jul;20(7):e2000024. doi: 10.1002/mabi.202000024. Epub 2020 Jun 17. Macromol Biosci. 2020. PMID: 32558365

3

Translating autologous heart valve tissue engineering from bench to bed.

Hjortnaes J, Bouten CV, Van Herwerden LA, Gründeman PF, Kluin J. Hjortnaes J, et al. Among authors: van herwerden la. Tissue Eng Part B Rev. 2009 Sep;15(3):307-17. doi: 10.1089/ten.TEB.2008.0565. Tissue Eng Part B Rev. 2009. PMID: 19450137 Review.

4

Platelet-lysate as an autologous alternative for fetal bovine serum in cardiovascular tissue engineering.

Riem Vis PW, Bouten CV, Sluijter JP, Pasterkamp G, van Herwerden LA, Kluin J. Riem Vis PW, et al. Among authors: van herwerden la. Tissue Eng Part A. 2010 Apr;16(4):1317-27. doi: 10.1089/ten.TEA.2009.0331. Tissue Eng Part A. 2010. PMID: 19908968

5

Environmental regulation of valvulogenesis: implications for tissue engineering.

Riem Vis PW, Kluin J, Sluijter JP, van Herwerden LA, Bouten CV. Riem Vis PW, et al. Among authors: van herwerden la. Eur J Cardiothorac Surg. 2011 Jan;39(1):8-17. doi: 10.1016/j.ejcts.2010.05.032. Epub 2010 Jul 15. Eur J Cardiothorac Surg. 2011. PMID: 20637649 Review.

6

Sequential use of human-derived medium supplements favours cardiovascular tissue engineering.

Riem Vis PW, Sluijter JP, Soekhradj-Soechit RS, van Herwerden LA, Kluin J, Bouten CV. Riem Vis PW, et al. Among authors: van herwerden la. J Cell Mol Med. 2012 Apr;16(4):730-9. doi: 10.1111/j.1582-4934.2011.01351.x. J Cell Mol Med. 2012. PMID: 21645237 Free PMC article.

7

Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves.

Dijkman PE, Driessen-Mol A, de Heer LM, Kluin J, van Herwerden LA, Odermatt B, Baaijens FP, Hoerstrup SP. Dijkman PE, et al. Among authors: van herwerden la. J Heart Valve Dis. 2012 Sep;21(5):670-8. J Heart Valve Dis. 2012. PMID: 23167234

8

Recurrent carcinoid involvement of a tricuspid bioprosthesis.

van Rijswijk JW, Vink A, van Herwerden LA, Kluin J. van Rijswijk JW, et al. Among authors: van herwerden la. Eur J Cardiothorac Surg. 2017 May 1;51(5):1015. doi: 10.1093/ejcts/ezw414. Eur J Cardiothorac Surg. 2017. PMID: 28040674 No abstract available.

9

Computed tomography detects tissue formation in a stented engineered heart valve.

de Heer LM, Budde RP, Vonken EJ, Baaijens FP, Gründeman PF, van Herwerden LA, Hoerstrup SP, Kluin J. de Heer LM, et al. Among authors: van herwerden la. Ann Thorac Surg. 2011 Jul;92(1):344-5. doi: 10.1016/j.athoracsur.2010.12.063. Ann Thorac Surg. 2011. PMID: 21718873

10

The pathophysiological basis of pharmacological interventions in CAVD.

Riem Vis PW, van Rijswijk JW, Chamuleau SA, Vink A, van Herwerden LA, Kluin J. Riem Vis PW, et al. Among authors: van rijswijk jw, van herwerden la. Neth Heart J. 2012 Jun;20(6):270-8. doi: 10.1007/s12471-011-0230-1. Neth Heart J. 2012. PMID: 22160992 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters